Bios
Venture capitalActively deployingFort Worth · 2 people tracked
Find your way into Bios
Fund manager profile
Bios is a venture fund manager based in Fort Worth. SEC filings show 5 venture funds on record, most recently Bios i-Lumen Co-Invest I, LP filed June 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 2 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro path
Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, a small-molecule GSK-3β inhibitor designed to treat difficult-to-treat cancers including pancreatic, melanoma, lung, and pediatric cancers through intravenous injection and oral tablet formulations.
BiotechFort Worth, US
Daniel Schmitt(President & Chief Executive Officer)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)
BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)
Board seatAaron Glenn Louis Fletcher· per SEC Form D · $50M raise · filed Dec 2020
Co-investorsIllinois VenturesKairos Venture Investments, LlcBios PartnersDEFTA PartnersTech Coast Angels
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsActuate TherapeuticsNASDAQ: ACTU
Portfolio news
latest coverage across their companies
Actuate Therapeutics · stocktitan.net · Aug 14, 2026
Frequently asked questions
- Where is Bios located?
- Bios is headquartered in Fort Worth, US.